| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |